Study of LP-184 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Apatinib and Fluzoparib With or Without Adebrelimab in Previously-treated TP53-mutant Advanced Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study on Food Influence and Drug-drug Interaction of HLX208 Tablets in Chinese Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Biomarker Screening Protocol for Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Status
- RECRUITING
- Phase
- NA
RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of XZB-0004 in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2